Khan T.K. (Ed.) Biomarker

InTech, 2012. — 392 p. — ISBN: 9535105770, 9789535105770.This scope of this book is not limited to just a few of the most important aspects of biomarkers but covers wide variety of subjects, from biomarkers cancer to neurodegenerative diseases. Chapters cover variety of aspects, from modern cell based technologies to molecular imaging; from drug discovery to critical care prognosis. A great amount of information is also devoted to bioinformatics and statistics.
The impact of biomarkers in present day health care system, health management and healthy life is enormous. Clinicians need them for diagnosis, prognosis, effect of therapeutic intervention, and most importantly, for early detection of a disease.
Pharmaceutical industries need them for new drug discovery and drug efficiency test.
Regulatory authorities need them for testing toxicity and environmental impact.
Epidemiologists need them for population screening and risk factor determination. In post genomic era biomarkers would have a huge impact in personalized medicine and personalized health management.
There is an enormous potential for commercial value of biomarkers.MicroRNAs are Novel Biomarkers for Detection of Colorectal Cancer
Epigenetics in Cancer: The Myelodysplastic Syndrome as a Model to Study Epigenetic Alterations as Diagnostic and Prognostic Biomarkers
Biomarkers in Gastrointestinal Cancer: Focus on Colon, Pancreatic and Gastric Cancer
Inorganic Signatures of Physiology: The X-Ray Fluorescence Microscopy Revolution
Urinary Water-Soluble Vitamins as Nutritional Biomarker to Estimate Their Intakes
Potential Muscle Biomarkers of Chronic Myalgia in Humans - A Systematic Review of Microdialysis Studies
Genotoxicity Biomarkers: Application in Histopathology Laboratories
Biomarkers and Therapeutic Drug Monitoring in Psychiatry
A Comparison of Biomarker and Fingerprint-Based Classifiers of Disease
8-Nitroguanine. a Potential Biomarker to Evaluate the Risk of Inflammation-Related Carcinogenesis
Profiling of Endogenous Peptides by Multidimensional Liquid Chromatography
Salivary Hormones, Immunes and Other Secretory Substances as Possible Stress Biomarker
Novel Tissue Types for the Development of Genomic Biomarkers
Computer Simulation Model System for Interpretation and Validation of Algorithms for Monitoring of Cancer Patients by Use of Serial Serum Concentrations of Biomarkers in the Follow-Up After Surgical Procedures and Other Treatments - A Computer Simulation Model System Based on the Breast Cancer Biomarker TPA
Using miRNAas Biomarkers to Evaluate the Alcohol-Induced Oxidative Stress
The Discovery of Cancer Tissue Specific Proteins in Serum: Case Studies on Prostate Cancer
Serum Peptidomics